Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation

Oral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical...

Full description

Saved in:
Bibliographic Details
Main Authors: Michael D. Brooks, Richard D. Bennett, Amy L. Weaver, Thomas J. Sebo, Steven E. Eckert, Emanuel E. Strehler, Alan B. Carr
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Dentistry
Online Access:http://dx.doi.org/10.1155/2013/592843
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560305164517376
author Michael D. Brooks
Richard D. Bennett
Amy L. Weaver
Thomas J. Sebo
Steven E. Eckert
Emanuel E. Strehler
Alan B. Carr
author_facet Michael D. Brooks
Richard D. Bennett
Amy L. Weaver
Thomas J. Sebo
Steven E. Eckert
Emanuel E. Strehler
Alan B. Carr
author_sort Michael D. Brooks
collection DOAJ
description Oral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical analysis using an affinity-purified CALML3 antibody was performed on biopsy-confirmed oral tissue samples representing these phases. A total of 90 tissue specimens were derived from 52 patients. Each specimen was analyzed in the superficial and basal mucosal cell layers for overall staining and staining of cellular subcompartments. CALML3 was strongly expressed in benign oral mucosal cells with downregulation of expression as squamous cells progress to invasive carcinoma. Based on the Cochran-Armitage test for trend, expression in the nucleus and at the cytoplasmic membrane significantly decreased with increasing disease severity. Chi-square test showed that benign tissue specimens had significantly more expression compared to dysplasia/CIS and invasive specimens. Dysplasia/CIS tissue had significantly more expression than invasive tissue. We conclude that CALML3 is expressed in benign oral mucosal cells with a statistically significant trend in downregulation as tumorigenesis occurs. CALML3 may thus be a sensitive new marker for oral cancer screening.
format Article
id doaj-art-33c26e94d84e42c3b88b3ec605e61823
institution Kabale University
issn 1687-8728
1687-8736
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Dentistry
spelling doaj-art-33c26e94d84e42c3b88b3ec605e618232025-02-03T01:27:49ZengWileyInternational Journal of Dentistry1687-87281687-87362013-01-01201310.1155/2013/592843592843Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant TransformationMichael D. Brooks0Richard D. Bennett1Amy L. Weaver2Thomas J. Sebo3Steven E. Eckert4Emanuel E. Strehler5Alan B. Carr6Peninsula Prosthodontics, 19365 7th Avenue NE, Suite 114, Poulsbo, WA 98370, USAPhysician Assistant Program, University of Charleston, 2300 MacCorkle Avenue SE, Riggleman Hall 130, Charleston, WV 25304, USADepartment of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USADepartment of Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USADepartment of Dental Specialties, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USADepartment of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USADepartment of Dental Specialties, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USAOral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical analysis using an affinity-purified CALML3 antibody was performed on biopsy-confirmed oral tissue samples representing these phases. A total of 90 tissue specimens were derived from 52 patients. Each specimen was analyzed in the superficial and basal mucosal cell layers for overall staining and staining of cellular subcompartments. CALML3 was strongly expressed in benign oral mucosal cells with downregulation of expression as squamous cells progress to invasive carcinoma. Based on the Cochran-Armitage test for trend, expression in the nucleus and at the cytoplasmic membrane significantly decreased with increasing disease severity. Chi-square test showed that benign tissue specimens had significantly more expression compared to dysplasia/CIS and invasive specimens. Dysplasia/CIS tissue had significantly more expression than invasive tissue. We conclude that CALML3 is expressed in benign oral mucosal cells with a statistically significant trend in downregulation as tumorigenesis occurs. CALML3 may thus be a sensitive new marker for oral cancer screening.http://dx.doi.org/10.1155/2013/592843
spellingShingle Michael D. Brooks
Richard D. Bennett
Amy L. Weaver
Thomas J. Sebo
Steven E. Eckert
Emanuel E. Strehler
Alan B. Carr
Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
International Journal of Dentistry
title Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
title_full Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
title_fullStr Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
title_full_unstemmed Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
title_short Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
title_sort human calmodulin like protein calml3 a novel marker for normal oral squamous mucosa that is downregulated in malignant transformation
url http://dx.doi.org/10.1155/2013/592843
work_keys_str_mv AT michaeldbrooks humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT richarddbennett humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT amylweaver humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT thomasjsebo humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT steveneeckert humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT emanuelestrehler humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation
AT alanbcarr humancalmodulinlikeproteincalml3anovelmarkerfornormaloralsquamousmucosathatisdownregulatedinmalignanttransformation